← Leaderboards
Adam Raymond Wende
University Of Utah
$4,582,213
Attributed
$4,786,400
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $594K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,786,400 · 6
By mechanism
R01$2,865,813 · 2
R00$870,392 · 1
R21$408,375 · 1
R56$367,500 · 1
K99$274,320 · 1
Top collaborators
- John C Chatham2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Omar Enrique Wever-Pinzon$993,600
- Claire Bensard$170,816
- Ahmad A Cluntun$470,354
- William L Holland$8,337,489
- You Han Bae$9,356,304
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsRegulationHeart FailurePost-Translational Protein ProcessingMolecularMitochondriaCardiac MyocytesMouse ModelCardiacHeartLinkFunctional DisorderEpigenetic ProcessMetabolicGene ExpressionGlucoseInsightMediatingDiabetes MellitusProteinsModificationDna MethylationCardiovascular SystemPlay
Grant awards (16)
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation$463,360
R01 · FY2025 · HL · contact PI
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation$454,093
R01 · FY2024 · HL · contact PI
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation$463,360
R01 · FY2023 · HL · contact PI
The role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology$185,625
R21 · FY2021 · HL
Glucose-Mediated Remodeling of Cardiac DNA Methylation$371,250
R01 · FY2020 · HL · contact PI
The role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology$222,750
R21 · FY2020 · HL
Glucose-Mediated Remodeling of Cardiac DNA Methylation$371,250
R01 · FY2019 · HL · contact PI
Glucose-Mediated Remodeling of Cardiac DNA Methylation$371,250
R01 · FY2018 · HL · contact PI
Glucose-Mediated Remodeling of Cardiac DNA Methylation$371,250
R01 · FY2017 · HL · contact PI
Glucose-Mediated Remodeling of Cardiac DNA Methylation$367,500
R56 · FY2016 · HL · contact PI
Mechanisms of glucose mediated cardiac mitochondrial dysfunction$245,266
R00 · FY2015 · HL · contact PI
Mechanisms of glucose mediated cardiac mitochondrial dysfunction$244,020
R00 · FY2014 · HL · contact PI
Mechanisms of glucose mediated cardiac mitochondrial dysfunction$144,059
R00 · FY2014 · HL · contact PI
Mechanisms of glucose mediated cardiac mitochondrial dysfunction$237,047
R00 · FY2013 · HL · contact PI
Mechanisms of glucose mediated cardiac mitochondrial dysfunction$137,160
K99 · FY2013 · HL · contact PI
Mechanisms of glucose mediated cardiac mitochondrial dysfunction$137,160
K99 · FY2012 · HL · contact PI